Medicus Pharma Ltd. (MDCX) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-06-04 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-27 | 8-K | Material Agreement, Direct Financial Obligation, Listing Notice, Financial Statements & Exhibits | SEC |
| 2026-04-24 | 8-K | Material Agreement, Listing Notice, Financial Statements & Exhibits | SEC |
| 2026-03-06 | 8-K | Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-12-30 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-12-08 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-12-01 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-14 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-17 | 8-K | Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-09-18 | 8-K | Material Agreement, Direct Financial Obligation, Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-12 | 8-K | Officer / Director Changes | SEC |
| 2025-09-02 | 8-K | Acquisition or Disposition, Unregistered Sales, Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-22 | 8-K | Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-04 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-30 | 8-K | Other Events | SEC |
| 2025-07-23 | 8-K | Shareholder Vote Results, Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-14 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-06-30 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-23 | 8-K | Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-20 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2025-06-05 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2025-06-02 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-05-05 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2025-04-28 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-25 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-11 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-02-11 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-26 | 6-K | FORM 6-K | SEC |
| 2024-12-12 | 6-K | FORM 6-K | SEC |
| 2024-12-02 | 6-K | FORM 6-K | SEC |
| 2024-11-25 | 6-K | FORM 6-K | SEC |
| 2024-11-18 | 6-K | FORM 6-K | SEC |
| 2024-11-18 | 6-K | FORM 6-K | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.